“Custom synthesis continued to lead growth for the ... will need to overcome the high product concentration of Sacubitril Valsartan in FY27. It thereby maintained a ‘hold’ rating with ...

Jefferies noted that Divi's custom synthesis business remained the primary ... address the high product concentration of Sacubitril Valsartan in FY27. Divi's sees GLP-1 as a key growth ...

Jefferies retained a ‘hold’ at Rs 6,280, noting strong custom synthesis growth and a better product mix but flagged pricing pressure in generics and the need to diversify beyond Sacubitril Valsartan ...

She is started on IV furosemide and maintained on her home guideline-directed medical therapy, including dapagliflozin, sacubitril-valsartan, metoprolol and ... 20, 21 Notably, impaired hemoglobin ...

Her startup, Modern Synthesis, still uses bacteria to grow nanocellulose fibers, but then it harvests and processes them to create a range of different materials. The new approach is more like ...

Chemical synthesis is the process by which one or more chemical reactions are performed with the aim of converting a reactant or starting material into a product or multiple products. Chemical ...

Natural product synthesis aims to prepare a complex target molecule such that the product is analytically identical to the naturally occurring compound, termed a natural product. It is used for ...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes LIC Housing Finance, Divi's Labs, Gland Pharma, ONGC and Aster DM, among others.

We evaluated the novel use of valsartan to attenuate the occurrence of and progression of pulmonary vein stenosis following total anomalous pulmonary venous connection surgery. Subclinical pulmonary ...